Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension

James P. Maloney, Robert S. Stearman, Todd M. Bull, David W. Calabrese, Megan L. Tripp-Addison, Marilee J. Wick, Ulrich Broeckel, Ivan M. Robbins, Lisa A. Wheeler, Joy D. Cogan, James E. Loyd

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Most patients with familial pulmonary arterial hypertension (FPAH) carry mutations in the bone morphogenic protein receptor 2 gene (BMPR2). Yet carriers have only a 20% risk of disease, suggesting that other factors influence penetrance. Thrombospondin-1 (TSP1) regulates activation of TGF-β and inhibits endothelial and smooth muscle cell proliferation, pathways coincidentally altered in pulmonary arterial hypertension (PAH). To determine whether a subset of FPAH patients also have mutations in the TSP1 gene (THBS1) we resequenced the type I repeats of THBS1 encoding the TGF-β regulation and cell growth inhibition domains in 60 FPAH probands, 70 nonfamilial PAH subjects, and in large control groups. We identified THBS1 mutations in three families: a novel missense mutation in two (Asp362Asn), and an intronic mutation in a third (IVS8+255 G/A). Neither mutation was detected in population controls. Mutant 362Asn TSP1 had less than half of the ability of wild-type TSP1 to activate TGF-β. Mutant 362Asn TSP1 also lost the ability to inhibit growth of pulmonary arterial smooth muscle cells and was over threefold less effective at inhibiting endothelial cell growth. The IVS8+255 G/A mutation decreased and/or eliminated local binding of the transcription factors SP1 and MAZ but did not affect RNA splicing. These novel mutations implicate THBS1 as a modifier gene in FPAH. These THBS1 mutations have implications in the genetic evaluation of FPAH patients. However, since FPAH is rare, these data are most relevant as evidence for the importance of TSP1 in pulmonary vascular homeostasis. Further examination of THBS1 in the pathogenesis of PAH is warranted.

Original languageEnglish (US)
Pages (from-to)L541-L554
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume302
Issue number6
DOIs
StatePublished - Mar 1 2012

Fingerprint

Thrombospondin 1
Pulmonary Hypertension
Mutation
Aptitude
Smooth Muscle Myocytes
Growth
Modifier Genes
RNA Splicing
Lung
Population Control
Penetrance
Missense Mutation
Genes
Blood Vessels
Homeostasis
Transcription Factors
Endothelial Cells
Cell Proliferation
Bone and Bones
Control Groups

Keywords

  • Endothelium
  • Genetics
  • Matricellular proteins
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension. / Maloney, James P.; Stearman, Robert S.; Bull, Todd M.; Calabrese, David W.; Tripp-Addison, Megan L.; Wick, Marilee J.; Broeckel, Ulrich; Robbins, Ivan M.; Wheeler, Lisa A.; Cogan, Joy D.; Loyd, James E.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 302, No. 6, 01.03.2012, p. L541-L554.

Research output: Contribution to journalArticle

Maloney, JP, Stearman, RS, Bull, TM, Calabrese, DW, Tripp-Addison, ML, Wick, MJ, Broeckel, U, Robbins, IM, Wheeler, LA, Cogan, JD & Loyd, JE 2012, 'Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension', American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 302, no. 6, pp. L541-L554. https://doi.org/10.1152/ajplung.00282.2011
Maloney, James P. ; Stearman, Robert S. ; Bull, Todd M. ; Calabrese, David W. ; Tripp-Addison, Megan L. ; Wick, Marilee J. ; Broeckel, Ulrich ; Robbins, Ivan M. ; Wheeler, Lisa A. ; Cogan, Joy D. ; Loyd, James E. / Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2012 ; Vol. 302, No. 6. pp. L541-L554.
@article{9c8a44de0ae84fc2a1f299dffafea5f3,
title = "Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension",
abstract = "Most patients with familial pulmonary arterial hypertension (FPAH) carry mutations in the bone morphogenic protein receptor 2 gene (BMPR2). Yet carriers have only a 20{\%} risk of disease, suggesting that other factors influence penetrance. Thrombospondin-1 (TSP1) regulates activation of TGF-β and inhibits endothelial and smooth muscle cell proliferation, pathways coincidentally altered in pulmonary arterial hypertension (PAH). To determine whether a subset of FPAH patients also have mutations in the TSP1 gene (THBS1) we resequenced the type I repeats of THBS1 encoding the TGF-β regulation and cell growth inhibition domains in 60 FPAH probands, 70 nonfamilial PAH subjects, and in large control groups. We identified THBS1 mutations in three families: a novel missense mutation in two (Asp362Asn), and an intronic mutation in a third (IVS8+255 G/A). Neither mutation was detected in population controls. Mutant 362Asn TSP1 had less than half of the ability of wild-type TSP1 to activate TGF-β. Mutant 362Asn TSP1 also lost the ability to inhibit growth of pulmonary arterial smooth muscle cells and was over threefold less effective at inhibiting endothelial cell growth. The IVS8+255 G/A mutation decreased and/or eliminated local binding of the transcription factors SP1 and MAZ but did not affect RNA splicing. These novel mutations implicate THBS1 as a modifier gene in FPAH. These THBS1 mutations have implications in the genetic evaluation of FPAH patients. However, since FPAH is rare, these data are most relevant as evidence for the importance of TSP1 in pulmonary vascular homeostasis. Further examination of THBS1 in the pathogenesis of PAH is warranted.",
keywords = "Endothelium, Genetics, Matricellular proteins, Vascular smooth muscle",
author = "Maloney, {James P.} and Stearman, {Robert S.} and Bull, {Todd M.} and Calabrese, {David W.} and Tripp-Addison, {Megan L.} and Wick, {Marilee J.} and Ulrich Broeckel and Robbins, {Ivan M.} and Wheeler, {Lisa A.} and Cogan, {Joy D.} and Loyd, {James E.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1152/ajplung.00282.2011",
language = "English (US)",
volume = "302",
pages = "L541--L554",
journal = "American Journal of Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension

AU - Maloney, James P.

AU - Stearman, Robert S.

AU - Bull, Todd M.

AU - Calabrese, David W.

AU - Tripp-Addison, Megan L.

AU - Wick, Marilee J.

AU - Broeckel, Ulrich

AU - Robbins, Ivan M.

AU - Wheeler, Lisa A.

AU - Cogan, Joy D.

AU - Loyd, James E.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Most patients with familial pulmonary arterial hypertension (FPAH) carry mutations in the bone morphogenic protein receptor 2 gene (BMPR2). Yet carriers have only a 20% risk of disease, suggesting that other factors influence penetrance. Thrombospondin-1 (TSP1) regulates activation of TGF-β and inhibits endothelial and smooth muscle cell proliferation, pathways coincidentally altered in pulmonary arterial hypertension (PAH). To determine whether a subset of FPAH patients also have mutations in the TSP1 gene (THBS1) we resequenced the type I repeats of THBS1 encoding the TGF-β regulation and cell growth inhibition domains in 60 FPAH probands, 70 nonfamilial PAH subjects, and in large control groups. We identified THBS1 mutations in three families: a novel missense mutation in two (Asp362Asn), and an intronic mutation in a third (IVS8+255 G/A). Neither mutation was detected in population controls. Mutant 362Asn TSP1 had less than half of the ability of wild-type TSP1 to activate TGF-β. Mutant 362Asn TSP1 also lost the ability to inhibit growth of pulmonary arterial smooth muscle cells and was over threefold less effective at inhibiting endothelial cell growth. The IVS8+255 G/A mutation decreased and/or eliminated local binding of the transcription factors SP1 and MAZ but did not affect RNA splicing. These novel mutations implicate THBS1 as a modifier gene in FPAH. These THBS1 mutations have implications in the genetic evaluation of FPAH patients. However, since FPAH is rare, these data are most relevant as evidence for the importance of TSP1 in pulmonary vascular homeostasis. Further examination of THBS1 in the pathogenesis of PAH is warranted.

AB - Most patients with familial pulmonary arterial hypertension (FPAH) carry mutations in the bone morphogenic protein receptor 2 gene (BMPR2). Yet carriers have only a 20% risk of disease, suggesting that other factors influence penetrance. Thrombospondin-1 (TSP1) regulates activation of TGF-β and inhibits endothelial and smooth muscle cell proliferation, pathways coincidentally altered in pulmonary arterial hypertension (PAH). To determine whether a subset of FPAH patients also have mutations in the TSP1 gene (THBS1) we resequenced the type I repeats of THBS1 encoding the TGF-β regulation and cell growth inhibition domains in 60 FPAH probands, 70 nonfamilial PAH subjects, and in large control groups. We identified THBS1 mutations in three families: a novel missense mutation in two (Asp362Asn), and an intronic mutation in a third (IVS8+255 G/A). Neither mutation was detected in population controls. Mutant 362Asn TSP1 had less than half of the ability of wild-type TSP1 to activate TGF-β. Mutant 362Asn TSP1 also lost the ability to inhibit growth of pulmonary arterial smooth muscle cells and was over threefold less effective at inhibiting endothelial cell growth. The IVS8+255 G/A mutation decreased and/or eliminated local binding of the transcription factors SP1 and MAZ but did not affect RNA splicing. These novel mutations implicate THBS1 as a modifier gene in FPAH. These THBS1 mutations have implications in the genetic evaluation of FPAH patients. However, since FPAH is rare, these data are most relevant as evidence for the importance of TSP1 in pulmonary vascular homeostasis. Further examination of THBS1 in the pathogenesis of PAH is warranted.

KW - Endothelium

KW - Genetics

KW - Matricellular proteins

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=84858176165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858176165&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00282.2011

DO - 10.1152/ajplung.00282.2011

M3 - Article

C2 - 22198906

AN - SCOPUS:84858176165

VL - 302

SP - L541-L554

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1040-0605

IS - 6

ER -